Article
HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals.
Antiviral research - 1 Feb 2021
Glebe Dieter, Goldmann Nora, Lauber Chris, Seitz Stefan
Abstract excerpt
Hepatitis B virus (HBV) poses a major global health burden with 260 million people being chronically infected and 890,000 dying annually from complications in the course of the infection. HBV is a small enveloped virus with a reverse-transcribed DNA genome that infects hepatocytes and can cause acute and chronic infections of the liver. HBV is endemic in humans and apes representing the prototype member of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
